Compared with NSCLC, MPLC has a distinct genetic mutation feature and the investigation of some prevalent mutations was currently lacking such as mutations in ZMIZ2 and MYO18A. This evidence concerns the gene ZMIZ2 and non-small cell lung carcinoma.